Announcements Trials
Browse Landscape

Status

Available 2No longer available 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 560Observational 113Expanded_access 3

Sponsor

Cancer Type

Gynecologic 9Gastrointestinal 6Sarcoma 5Genitourinary 5Thoracic 4Dermatologic 3Breast 3CNS 2Lymphoid 1Head & Neck 1

Conditions

Breast Neoplasms 18Triple Negative Breast Neoplasms 6Pancreatic Neoplasms 5Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Ovarian Neoplasms 3HER2-positive Breast Cancer 3Sarcoma 2Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Brain Neoplasms 2Triple Negative Local Advanced Breast Cancer 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Neoplasm Metastasis 1Metastatic gpNMB Expressing Triple Negative Breast Cancer 1Melanoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Head and Neck Neoplasms 1Glioblastoma 1Colonic Neoplasms 1Chordoma 1Chondrosarcoma 1Cholangiocarcinoma 1

Interventions

pegilodecakin 1Proton Pump Inhibitors 1Hydrocortisone 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Expanded_access × Ovarian Neoplasms × Breast × Clear all
NCT04091295 2026-03-04

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Aveni Foundation

Available
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT03554434 2020-03-02

An Expanded Access Program for AM0010 (Pegilodecakin)

Eli Lilly and Company

No longer available
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡